Previously treated cases tested for RR-/MDR-TB (%) in Democratic Republic of Congo

Democratic Republic of Congo: Previously treated cases tested for RR-/MDR-TB was 85.0% in 2024. ◆ Volatile

Latest (2024)
85.0%
Change on year
up 21.4%
World rank
100th
of 180 countries
All-time high
98.0%
in 2020
All-time low
1.2%
in 2006
Years of data
19
2006–2024

Previously treated cases tested for RR-/MDR-TB in Democratic Republic of Congo, 2006–2024

0204060801002006201520242006: 1.22007: 1.82008: 2.52009: 1.32010: 1.22011: 22012: 1.42013: 142014: 752015: 762016: 5.82017: 572018: 662019: 862020: 982021: 812022: 852023: 702024: 85

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for previously treated cases tested for rr-/mdr-tb in Democratic Republic of Congo is 85.0%, measured in 2024.

The figure is up 21.4% on the previous year and up 13.3% over ten years.

Over the whole period, previously treated cases tested for rr-/mdr-tb in Democratic Republic of Congo peaked at 98.0% in 2020 and was at its lowest, 1.2%, in 2006.

That places Democratic Republic of Congo 100th out of 180 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Previously treated cases tested for RR-/MDR-TB in Democratic Republic of Congo, year by year

Annual values for Previously treated cases tested for RR-/MDR-TB (%) in Democratic Republic of Congo, 2006 to 2024.
Year Value Change
2006 1.2% —
2007 1.8% +50.0%
2008 2.5% +38.9%
2009 1.3% -48.0%
2010 1.2% -7.7%
2011 2.0% +66.7%
2012 1.4% -30.0%
2013 14.0% +900.0%
2014 75.0% +435.7%
2015 76.0% +1.3%
2016 5.8% -92.4%
2017 57.0% +882.8%
2018 66.0% +15.8%
2019 86.0% +30.3%
2020 98.0% +14.0%
2021 81.0% -17.3%
2022 85.0% +4.9%
2023 70.0% -17.6%
2024 85.0% +21.4%

Democratic Republic of Congo compared with similar countries

  • Democratic Republic of Congo's 85.0% is below the median for low income countries, which is 87.0%, 98% of the median. (24 countries reporting)
  • Democratic Republic of Congo's 85.0% is below the median for Sub-Saharan Africa, which is 91.5%, 93% of the median. (46 countries reporting)

Biggest year-on-year movements

Years where Previously treated cases tested for RR-/MDR-TB in Democratic Republic of Congo changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2013 +900.0% 1.4% 14.0%
2017 +882.8% 5.8% 57.0%
2014 +435.7% 14.0% 75.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 1.7% 1.2% 2.5% 4
2010s 38.4% 1.2% 86.0% 10
2020s 83.8% 70.0% 98.0% 5

Countries ranked near Democratic Republic of Congo

  1. 97 Uzbekistan 86.0% compare
  2. 97 Turkey 86.0% compare
  3. 97 India 86.0% compare
  4. 100 Mexico 85.0% compare
  5. 100 Guatemala 85.0% compare
  6. 103 Greece 84.0% compare

See the full ranking of 193 places →

More health data for Democratic Republic of Congo

All data for Democratic Republic of Congo →

Frequently asked questions

What is previously treated cases tested for rr-/mdr-tb in Democratic Republic of Congo?
Previously treated cases tested for rr-/mdr-tb in Democratic Republic of Congo was 85.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest previously treated cases tested for rr-/mdr-tb recorded in Democratic Republic of Congo?
The highest recorded value was 98.0% in 2020.
What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Democratic Republic of Congo?
The lowest recorded value was 1.2% in 2006.
How does Democratic Republic of Congo rank for previously treated cases tested for rr-/mdr-tb?
Democratic Republic of Congo ranks 100th out of 180 countries with data for 2024.
Is previously treated cases tested for rr-/mdr-tb rising or falling in Democratic Republic of Congo?
Over the last ten years it is up 13.3%. The long-run trend across the full record is volatile.
Where does this Democratic Republic of Congo data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 19 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Previously treated cases tested for RR-/MDR-TB in Democratic Republic of Congo. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 07 October 2026, from https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/congo-dem-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/congo-dem-rep/">Previously treated cases tested for RR-/MDR-TB in Democratic Republic of Congo</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed